BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34152686)

  • 1. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome.
    Reike-Kunze M; Zenouzi R; Hartel J; Krech T; Weidemann S; Sterneck M; Weiler-Normann C; Lohse AW; Schramm C; Sebode M
    Liver Int; 2021 Oct; 41(10):2383-2395. PubMed ID: 34152686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metamizole: An underrated agent causing severe idiosyncratic drug-induced liver injury.
    Sebode M; Reike-Kunze M; Weidemann S; Zenouzi R; Hartl J; Peiseler M; Liwinski T; Schulz L; Weiler-Normann C; Sterneck M; Lohse AW; Schramm C
    Br J Clin Pharmacol; 2020 Jul; 86(7):1406-1415. PubMed ID: 32080881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury.
    Jeong R; Lee YS; Sohn C; Jeon J; Ahn S; Lim KS
    Scand J Gastroenterol; 2015 Apr; 50(4):439-46. PubMed ID: 25639449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.
    Lo Re V; Haynes K; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Leidl KB; Reddy KR; Nezamzadeh MS; Roy J; Sha D; Marks AR; De Boer J; Schneider JL; Strom BL; Corley DA
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2360-8. PubMed ID: 26122767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prognostic models for mortality in idiosyncratic drug-induced liver injury.
    Wang Y; Zou C; Wee A; Liu J; Ma Z; Guo T; Li M; Wang Y; Liu L; Jia J; Zou Z; Zhao X
    Hepatol Int; 2023 Apr; 17(2):488-498. PubMed ID: 36327052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
    Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
    Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
    J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements.
    Nash E; Sabih AH; Chetwood J; Wood G; Pandya K; Yip T; Majumdar A; McCaughan GW; Strasser SI; Liu K
    Med J Aust; 2021 Sep; 215(6):261-268. PubMed ID: 34272737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study to evaluate Hy's Law, DrILTox ALF score, Robles-Diaz model, and a new logistic regression model for predicting acute liver failure in Chinese patients with drug-induced liver injury.
    Xiong X; Xu Q; Wang B
    Expert Opin Drug Saf; 2024 Feb; 23(2):207-211. PubMed ID: 36958375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death and liver transplantation within 2 years of onset of drug-induced liver injury.
    Hayashi PH; Rockey DC; Fontana RJ; Tillmann HL; Kaplowitz N; Barnhart HX; Gu J; Chalasani NP; Reddy KR; Sherker AH; Hoofnagle JH;
    Hepatology; 2017 Oct; 66(4):1275-1285. PubMed ID: 28543844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
    Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
    Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
    Baekdal M; Ytting H; Skalshøi Kjær M
    Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event.
    Weber S; Benesic A; Neumann J; Gerbes AL
    Drug Saf; 2021 Jun; 44(6):669-680. PubMed ID: 33638811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients.
    Devarbhavi H; Patil M; Reddy VV; Singh R; Joseph T; Ganga D
    Liver Int; 2018 Jul; 38(7):1322-1329. PubMed ID: 29222960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel predictors for liver transplantation or death in drug-induced acute liver failure.
    Weber S; Woischke C; Denk G; Gerbes AL
    Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):422-425. PubMed ID: 34432679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury.
    Borlak J; van Bömmel F; Berg T
    Liver Int; 2018 Feb; 38(2):365-376. PubMed ID: 28782153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.